Organization
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, Hong Kong
1 abstract
Abstract
Role of plasma circulating HER2/EFTUD2 ratio in predicting pathological complete response (pCR) after neoadjuvant dual anti-HER2 therapy in HER2-positive breast cancer (HER2+ BC).Org: Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, Hong Kong, Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, Hong Kong, Departments of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, Hong Kong, Queen Elizabeth Hospital, Kowloon, Hong Kong, Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong, Hong Kong,